The company said in a state Worker Adjustment and Retraining Notification note Nov. 8 that it will cut 149 people at its research facility in Kendall Square. The move comes just a few years after the company expanded to New England from its headquarters in Thousand Oaks, Calif.
Amgen will consolidate the rest of its U.S.-based research work at its Thousand Oaks headquarters and San Francisco offices. A spokesperson did not immediately say what would happen to the rest of the Cambridge-based employees, according to the Boston Business Journal.
The decision comes around the same time the company acquired a 20 percent stake in Chinese drugmaker BeiGene for $2.7 billion.
Read the full article here.
More articles on pharmacy:
Endo CEO to retire
Trump administration sues Gilead
CVS to close 22 ‘underperforming’ stores
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.